These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15934915)

  • 1. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.
    Harwood HJ
    Expert Opin Ther Targets; 2005 Apr; 9(2):267-81. PubMed ID: 15934915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.
    Harwood HJ
    Curr Opin Investig Drugs; 2004 Mar; 5(3):283-9. PubMed ID: 15083594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of mammalian acetyl-CoA carboxylase.
    Corbett JW; Harwood JH
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):162-80. PubMed ID: 18221116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
    Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
    J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
    Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
    Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
    Harriman G; Greenwood J; Bhat S; Huang X; Wang R; Paul D; Tong L; Saha AK; Westlin WF; Kapeller R; Harwood HJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1796-805. PubMed ID: 26976583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs.
    Wu X; Huang T
    Future Med Chem; 2020 Mar; 12(6):533-561. PubMed ID: 32048880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acetyl-CoA carboxylase enzyme: a target for cancer therapy?
    Wang C; Ma J; Zhang N; Yang Q; Jin Y; Wang Y
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):667-76. PubMed ID: 25979092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
    Corbett JW
    Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, function and selective inhibition of bacterial acetyl-coa carboxylase.
    Polyak SW; Abell AD; Wilce MC; Zhang L; Booker GW
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):983-92. PubMed ID: 22183085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes.
    Cheng D; Chu CH; Chen L; Feder JN; Mintier GA; Wu Y; Cook JW; Harpel MR; Locke GA; An Y; Tamura JK
    Protein Expr Purif; 2007 Jan; 51(1):11-21. PubMed ID: 16854592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclohexanedione herbicides are inhibitors of rat heart acetyl-CoA carboxylase.
    Seng TW; Skillman TR; Yang N; Hammond C
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3237-42. PubMed ID: 12951100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
    Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
    Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl CoA carboxylase shares control of fatty acid synthesis with fatty acid synthase in bovine mammary homogenate.
    Wright TC; Cant JP; Brenna JT; McBride BW
    J Dairy Sci; 2006 Jul; 89(7):2552-8. PubMed ID: 16772574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.
    Bourbeau MP; Siegmund A; Allen JG; Shu H; Fotsch C; Bartberger MD; Kim KW; Komorowski R; Graham M; Busby J; Wang M; Meyer J; Xu Y; Salyers K; Fielden M; Véniant MM; Gu W
    J Med Chem; 2013 Dec; 56(24):10132-41. PubMed ID: 24294923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential.
    Luo DX; Tong DJ; Rajput S; Wang C; Liao DF; Cao D; Maser E
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):168-84. PubMed ID: 22339356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.
    Schreurs M; Kuipers F; van der Leij FR
    Obes Rev; 2010 May; 11(5):380-8. PubMed ID: 19694967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of acetyl-CoA carboxylase (ACC) inhibitors for the treatment of metabolic disease.
    Bourbeau MP; Bartberger MD
    J Med Chem; 2015 Jan; 58(2):525-36. PubMed ID: 25333641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2.
    Corbett JW; Freeman-Cook KD; Elliott R; Vajdos F; Rajamohan F; Kohls D; Marr E; Zhang H; Tong L; Tu M; Murdande S; Doran SD; Houser JA; Song W; Jones CJ; Coffey SB; Buzon L; Minich ML; Dirico KJ; Tapley S; McPherson RK; Sugarman E; Harwood HJ; Esler W
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2383-8. PubMed ID: 20219367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
    Marjanovic J; Chalupska D; Patenode C; Coster A; Arnold E; Ye A; Anesi G; Lu Y; Okun I; Tkachenko S; Haselkorn R; Gornicki P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9093-8. PubMed ID: 20439761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.